Dennis McKinley, ABB Inc. and Alex Brindle, NNE PharmaPlan

Articles

IIoT, Industrie 4.0 November 1, 2009

PAT enables process development, manufacturing

Most biopharmaceutical facilities today are based on batch processes and unit operations. The process is run through one unit operation until completed, based on the application to the FDA for the product/drug being manufactured. Once the unit operation is complete, typically a sample of the batch is taken to a lab for analysis to determine whether it has met the criteria for the specific unit ...

By Dennis McKinley, ABB Inc. and Alex Brindle, NNE PharmaPlan
All Articles